Somatic stem cells
US9777259B2 · kind B2 · utility
0Cited by
14References
7Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 7, 2015 |
| Grant date | Oct 3, 2017 |
| Priority date | — |
| Expiry date | Apr 15, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/415
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A somatic stem cell that is CD10+, CXCR4+, and CD31+ and another somatic stem cell that is CD105+, CD44+, and nestin+. Also disclosed are both a method of preparing these stem cells and a method of using them to treat degenerative diseases, e.g., a muscle-degenerative disease. The invention further includes making and using liver cells derived from the somatic cell that is CD105+, CD44+, and nestin+.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.